Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-12-13

Clinical Trial Update: Cytoreduction With or Without Intraoperative Intraperitoneal Hyperthermic Chemotherapy (HIPEC) in Patients With Peritoneal Carcinomatosis From Ovarian Cancer, Fallopian Tube or Primary Peritoneal Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating cytoreduction with or without intraoperative intraperitoneal hyperthermic chemotherapy (HIPEC) for peritoneal carcinomatosis a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia | Conditions: Peritoneal Carcinomatosis From Ovarian Cancer, Fallopian Tube Carcinoma | Phase 3 | Status: UNKNOWN